Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors

NCT02559492 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT02559492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02559492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2015
Completion date
August 18, 2019
Enrollment
142 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors